News
Latest News
Our Recent Posts
Trauma Intact Results and News
Pharmacokinetic TRAUMAINTACT trial results show TXA is well tolerated & rapidly absorbed via IM route in bleeding trauma patients
Details
PREVENTT Trial Results and News
Preoperative IV iron is NOT superior to placebo to reduce need for blood transfusion when given to anaemia patients 10–42 days before elective major abdominal surgery
Details
HALT-IT Trial Results and News
HALT-IT trial found that TXA does NOT reduce deaths from stomach bleeding but increases the risk of thromboembolic events (deep vein thrombosis or pulmonary embolism)
Details
The CRASH-3 Results and News
Tranexamic Acid (TXA) is a safe, low cost, and widely available drug which could prevent deaths from TBI by as much as 20% depending on severity of the injury
Details
ISTH TV: The importance of giving TXA early to trauma & PPH patients
Watch Prof Ian Roberts on International Society on Thrombosis and Hemostasis Daily News, discussing the importance of giving TXA early to trauma & PPH patients
Details
Clinical trial managers need recognition for their work
Expert trial managers with the training and experience to overcome operational challenges are often the difference between the success and failure of a clinical trial.
Details
WOMAN Trial Results and News
Can we prevent women from dying after childbirth? The WOMAN trial showed that if given within 3 hours, TXA can reduce the risk of death due to bleeding by one third.
Details
The CRASH-2 Results and News
Global trial CRASH-2 is now complete and shows new hopes to cut deaths from serious injury – a simple jab of Tranexamic Acid could save up to 100,000 lives a year.
Details- 1
- 2